09.07.2025 • News

Azelis Acquires Italian Specialty Chemicals Distributor ACEF

Azelis has acquired Azienda Chimica e Farmaceutica (‘ACEF’), a distributor of speciality raw materials and ingredients for the cosmetic, nutraceutical, galenic, and pharma industries in Italy.

Company representatives from Azelis and ACEF
Customers will benefit from access to a broader combined portfolio, as well as wider technical capabilities and market-specific expertise.
© Azelis

Founded in 1940 in Piacenza, ACEF operates three laboratories for technical support and quality control, as well as GMP-compliant facilities for pharmaceutical ingredients. Its subsidiary, Arda Natura, specialises in plant extracts and other natural products.  

ACEF serves over 4,000 customers in the cosmetics, pharmaceuticals, galenic products, and nutraceutical markets. Its broad portfolio strategically complements Azelis’s lateral value chain for the relevant end markets. With this acquisition, Azelis significantly expands its footprint in Italy and strengthens its position as industry leader in the relevant end markets

Alberto Piombi, President, and Emilio Zavattoni, CEO and Head of Administration & Finance at ACEF, commented: “We recognise the high-quality solutions that Azelis provides to its principals and customers, so joining forces is an exciting opportunity for ACEF. With our laboratory capabilities and tailor-made services, we look forward to adding our talents to those of the Azelis teams, leveraging our combined skills to reinforce our position as a leading distributor and bring the best solutions to our customers.”

Marco Gerosa, Managing Director at Azelis Italy, added: “We are pleased to welcome ACEF to the Azelis group, bringing together skilled teams and creating opportunities for people to grow. We continuously strive to deliver innovation through formulation, and ACEF’s value proposition fits perfectly with our objective. The addition of their portfolio and technical capabilities reinforces our footprint in the personal care and galenic markets and expands our pharmaceutical and nutraceutical offerings. This acquisition is another demonstration of our commitment to our purpose of enabling our customers to win and our principals to grow.”

Company

Logo:

Azelis Corporate Services NV

12 box 6, Posthofbrug
2600 Antwerpen
Belgium

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read